The Indian government has taken a decisive step by restricting the use of certain fixed-dose cough syrup combinations in children under the age of four. This regulation specifically targets syrups containing chlorpheniramine maleate and phenylephrine hydrochloride. The decision comes in the wake of medical experts raising alarms about potential safety risks.
The primary concern revolves around the safety of young children. Medical professionals have highlighted serious risks such as slowed breathing, excessive drowsiness, and the potential for overdose. These concerns were echoed by international alerts and domestic expert reviews, prompting the government to act decisively.
There have been reports from doctors and pediatricians indicating that these ingredients can cause significant issues such as excessive drowsiness and respiratory distress. In some rare instances, the consequences were more severe, potentially leading to fatalities due to undeveloped metabolism and tolerance in very young children.
Concerns regarding these medications are not new in India. Several other countries have already imposed similar restrictions. Indian pediatricians have been vocal about these issues for years, though formal action had been pending until now.
The restriction was officially formalized by the Health Ministry on April 15, 2025, following the recommendations of the Drug Technical Advisory Board. This move ensures the safety of children by enforcing stricter control over the distribution and usage of these cough syrups.
The Centre has instructed all state drug controllers to recall the affected syrups and halt their production. Manufacturers are required to update labels to warn against usage in children under four. Pharmacies are advised to return existing stocks and refrain from prescribing these syrups to young children.
While doctors can still prescribe other types of cough syrups, there is a growing emphasis on safer alternatives. Options such as saline nasal drops or steam inhalation are encouraged, and unnecessary medication for mild infections should be avoided.
For parents and caregivers, this decision underscores the importance of avoiding over-the-counter cold medications for toddlers unless specifically advised by a pediatrician. It is crucial to carefully read labels and seek professional medical advice when necessary.
Kutos : AI Assistant!
